Literature DB >> 2876232

Prenatal diagnosis of alpha 1-antitrypsin deficiency by restriction fragment length polymorphisms, and comparison with oligonucleotide probe analysis.

J F Hejtmancik, R N Sifers, P A Ward, S Harris, T Mansfield, D W Cox.   

Abstract

Prenatal diagnosis of sixteen pregnancies at risk for alpha 1-antitrypsin (AAT) deficiency has been achieved by restriction fragment length polymorphism (RFLP) analysis and compared with diagnostic results using hybridisation of M and Z specific oligonucleotides. The results of both tests were in accord for all samples, although under routine laboratory conditions RFLP analysis was more reliable. Because RFLP analysis does not depend on the type of mutation it was possible, in the product of an MZ and SZ mating, to predict an MZ rather than an MS phenotype using the RFLP method. The strong linkage dysequilibrium between an AvaII RFLP and the Z allele increases its diagnostic usefulness. Even so it seems reasonable to use oligonucleotide analysis in families where no siblings are available for comparison. In all other situations RFLP analysis is as accurate and reliable as oligonucleotide analysis and is technically easier, making it the preferred means of diagnosis for informative kindreds.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876232     DOI: 10.1016/s0140-6736(86)90297-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Defining DNA diagnostic tests appropriate or standard clinical care.

Authors:  R V Lebo; G Cunningham; M J Simons; L J Shapiro
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

2.  Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Authors:  Shannon D Barker; Sherri Bale; Jessica Booker; Arlene Buller; Soma Das; Kenneth Friedman; Andrew K Godwin; Wayne W Grody; Edward Highsmith; Jeffery A Kant; Elaine Lyon; Rong Mao; Kristin G Monaghan; Deborah A Payne; Victoria M Pratt; Iris Schrijver; Antony E Shrimpton; Elaine Spector; Milhan Telatar; Lorraine Toji; Karen Weck; Barbara Zehnbauer; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

3.  DNA haplotyping of PI Z and M alleles within the German population.

Authors:  C Meisen; W Poller; K Olek
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

4.  DNA restriction-site polymorphisms associated with the alpha 1-antitrypsin gene.

Authors:  D W Cox; G D Billingsley; T Mansfield
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

5.  Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products.

Authors:  C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

Review 6.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

7.  Prenatal diagnosis of alpha-1-antitrypsin deficiency using oligonucleotide probe analysis.

Authors:  C Meisen; M Higuchi; S Bräutigam; A J Driesel; M Blandfort; K Olek
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

8.  Prenatal diagnosis of alpha 1 antitrypsin deficiency and estimates of fetal risk for disease.

Authors:  D W Cox; T Mansfield
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.